Larimar Therapeutics Inc
F:ZA71
Larimar Therapeutics Inc
F:ZA71
Price:
3
EUR
-0.66%
Market Closed
Market Cap:
€191.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Larimar Therapeutics Inc
F:ZA71
|
US |
|
G
|
Givaudan SA
XMUN:GIN
|
CH |
|
U
|
UBE Corp
DUS:UBE
|
JP |
|
Kid ASA
F:97Q
|
NO |
|
M
|
Mckesson Corp
F:MCK
|
US |
|
Larimar Therapeutics Inc
NASDAQ:LRMR
|
US |
Wall St Price Targets
ZA71 Price Targets Summary
Larimar Therapeutics Inc
Larimar Therapeutics Inc
Wall Street analysts forecast ZA71 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ZA71 is 13.46 EUR with a low forecast of 5.75 EUR and a high forecast of 22.21 EUR.
Lowest Forecast
Price Target
5.75
EUR
92% Upside
Average Forecast
Price Target
13.46
EUR
349% Upside
Highest Forecast
Price Target
22.21
EUR
640% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ZA71's stock price target?
Price Target
13.46
EUR
13.46
EUR
According to Wall Street analysts, the average 1-year price target for ZA71 is 13.46 EUR with a low forecast of 5.75 EUR and a high forecast of 22.21 EUR.
